News

Apnimed, Inc., a pharmaceutical company advancing an industry-leading pipeline of first-in-class oral therapies that address the root causes of obstructive sleep apnea (OSA) and other sleep-related ...
New genetic research reveals polygenic scores can predict obesity risk, offering early prevention insights while raising ...